About the Authors
- J. Peter Svensson, Rebecca E. E. Esveldt–van Lange, Binie Klein, Harry Vrieling, Micheline Giphart-Gassler
- Department of Toxicogenetics, Leiden University Medical Center, Leiden, Netherlands
- J. Peter Svensson, Ingela Turesson
- Department of Oncology, Radiology, and Clinical Immunology, Academic Hospital, Uppsala, Sweden
- Lukas J. A Stalpers, Nicolaas A. P Franken, Jaap Haveman
- Department of Radiotherapy/LEXOR Laboratory of Experimental Oncology and Radiobiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
The authors have declared that no competing interests exist.
LJAS, NAPF, JH, HV, and MGG initiated the study. LJAS, NAPF, and JH enrolled patients and collected clinical material. LJAS analyzed clinical data. JPS, REEEvL, and BK did the laboratory experiments. JPS analyzed the gene expression data. HV, LJAS, and MGG supervised the study. JPS, LJAS, NAPF, JH, IT, HV, and MGG contributed to writing the paper.